1. Effect of craniosacral therapy on lower urinary tract signs and symptoms in multiple sclerosis.

Raviv G, Shefi S, Nizani D, Achiron A.

http://www.ncbi.nlm.nih.gov/pubmed/19341983

 

Source

Urology Department, Sheba Medical Center, Tel Hashomer, Israel. gravivg@zahav.net.il

Abstract

To examine whether craniosacral therapy improves lower urinary tract symptoms of multiple sclerosis (MS) patients. A prospective cohort study. Out-patient clinic of multiple sclerosis center in a referral medical center. Hands on craniosacral therapy (CST). Change in lower urinary tract symptoms, post voiding residual volume and quality of life. Patients from our multiple sclerosis clinic were assessed before and after craniosacral therapy. Evaluation included neurological examination, disability status determination, ultrasonographic post voiding residual volume estimation and questionnaires regarding lower urinary tract symptoms and quality of life. Twenty eight patients met eligibility criteria and were included in this study. Comparison of post voiding residual volume, lower urinary tract symptoms and quality of life before and after craniosacral therapy revealed a significant improvement (0.001>p>0.0001). CST was found to be an effective means for treating lower urinary tract symptoms and improving quality of life in MS patients.

PMID: 19341983

[PubMed - indexed for MEDLINE]

 

2. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.

Olsen SA.

http://www.ncbi.nlm.nih.gov/pubmed/19222053

 

Source

MultiCare Health Systems, 315 Martin Luther King Jr. Way, Tacoma, WA. olsenls1515msn.com

Abstract

Multiple sclerosis (MS) is a chronic, unpredictable disease of the central nervous system without a known cure. Because of this, people with MS often seek complementary and alternative medicines (CAM) to manage their disease symptoms. The goal of this review article was to describe the use of CAM by individuals diagnosed with MS. Evidence was obtained by searching Medline (1950-2007), EBSCOhost and PubMed for studies relating CAM to MS. Results from the literature showed that people with MS reported that they used CAM from 27 to 100%. The major reasons for choosing CAM were as follows: conventional treatment was not effective, anecdotal reports of CAM's help, and doctor referral. The types of CAM reported by people with MS included exercise, vitamins, herbal and mineral supplements, relaxation techniques, acupuncture, cannabis and massage. The major symptoms treated by CAM as noted in the literature were pain, fatigue and stress. There is a need for further research to evaluate the effectiveness of CAM with MS patients and their application by occupational therapists. The limitation of this literature review was the low response rate in many of the surveys reported.

2009 John Wiley & Sons, Ltd

PMID: 19222053

[PubMed - indexed for MEDLINE]

 

3. Complementary therapy use by persons with multiple sclerosis: benefits and research priorities.

Esmonde L, Long AF.

http://www.ncbi.nlm.nih.gov/pubmed/18640629

 

Source

School of Healthcare, University of Leeds, Baines Wing, Leeds LS2 9UT, UK.

Abstract

People with multiple sclerosis (MS) are commonly actively involved in self-care, with many accessing complementary and alternative medicine (CAM) to help in symptom management. To provide increased insight into benefits from CAM use and service user ideas over research priorities, a two-part study, involving a questionnaire and interactive workshop, was undertaken with attendees at a national Congress of the MS Trust in the UK. The six most used therapies were reflexology, massage, yoga, relaxation and meditation, acupuncture and aromatherapy. Each was rated by a quarter to two-fifths as 'extremely helpful'. Insight into the nature of the therapeutic benefit was provided in user comments. Despite the self-selected nature of the sample, the findings point to potential benefits of a set of CAM therapies in helping people with MS. More research on potential benefits of therapies was called for by participants and on the dynamics of the therapeutic effect.

PMID: 18640629

[PubMed - indexed for MEDLINE]

 

4. Predictors of alternative medicine use by multiple sclerosis patients.

Marrie RA, Hadjimichael O, Vollmer T.

http://www.ncbi.nlm.nih.gov/pubmed/14582770

 

Source

Mellen Center for MS Treatment and Research, U10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. marrier@ccf.org

Abstract

OBJECTIVE:

To determine the frequency of alternative medicine use among multiple sclerosis (MS) patients, and the factors which predict such use.

METHODS:

We examined 20778 MS patients enrolled in the North American Research Consortium on Multiple Sclerosis (NARCOMS) Patient Registry, residing in the USA. We used demographic and clinical data to create multivariate logistic regression models for i) lifetime use of any alternative medicine, ii) lifetime use of any alternative provider (AP), and iii) lifetime use of each of the three most common AP.

RESULTS:

20387 patients provided data regarding alternative medicine use. Lifetime use of any alternative medicine was 54% and current use was 30%. Chiropractors (51%), massage therapists (34%), and nutritionists (24%) were the most commonly used AP. In all five models, use of alternative medicine was most strongly predicted by use of a conventional provider, and more modestly by disease factors indicating more severe or prolonged disease. Predictive power of the models was poor (c-index = 0.62-0.68), despite good fits for the data.

CONCLUSIONS:

Demographic factors play only a minimal role in predicting the use of alternative medicine in this MS population while disease factors play a slightly stronger role. There must be other factors involved that may include accessibility, social acceptability and cultural factors. Given the frequency of alternative medicine use by this patient population, further characterization of these factors is important.

PMID: 14582770

[PubMed - indexed for MEDLINE]